US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco KBW Premium Yield Equity REIT ETF

16.33

-0.2100-1.27%

Post-market: 16.330.00000.00%19:43 EDT

Volume:294.87K

Turnover:4.84M

Market Cap:290.51M

PE:- -

High:16.51

Open:16.51

Low:16.28

Close:16.54

52wk High:19.35

52wk Low:14.82

Shares:17.79M

Float Shares:17.79M

Volume Ratio:0.92

T/O Rate:1.66%

Dividend:1.48

Dividend Rate:9.06%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly

Climb Bio to Present New Data at American Society of Nephrology (ASN) Kidney Week 2026 for CLYM116 and Budoprutug

Innovative Industrial Properties initiated with an Outperform at Huntington

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/KBWY"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KBWY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KBWY\",,,,,undefined,":{"symbol":"KBWY","market":"US","secType":"STK","nameCN":"Invesco KBW Premium Yield Equity REIT ETF","latestPrice":16.33,"timestamp":1791230400000,"preClose":16.54,"halted":0,"volume":294869,"hourTrading":{"tag":"盘后","latestPrice":16.33,"preClose":16.33,"latestTime":"19:43 EDT","volume":287,"amount":4697.4313,"timestamp":1791243830900,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.012696493349455917,"floatShares":17790000,"shares":17790000,"eps":0,"marketStatus":"Not Yet Opened","change":-0.21,"latestTime":"10-05 16:00:00 EDT","open":16.51,"high":16.51,"low":16.28,"amount":4836783.9757779995,"amplitude":0.013906,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791273600000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":16.54,"sharesOutstanding":16420000,"nav":16.53534,"aum":292840871.4,"dividendRate":0.0906,"bidAskSpread":0.000605,"preHourTrading":{"tag":"盘前","latestPrice":16.5,"preClose":16.54,"latestTime":"09:29 EDT","volume":3897,"amount":64334.341548,"timestamp":1791206999999,"change":-0.04,"changeRate":-0.002418,"amplitude":0.014208},"postHourTrading":{"tag":"盘后","latestPrice":16.33,"preClose":16.33,"latestTime":"19:43 EDT","volume":287,"amount":4697.4313,"timestamp":1791243830900,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.920678,"impliedVol":0,"impliedVolPercentile":0.056},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KBWY\",,,,,undefined,":{"symbol":"KBWY","floatShares":17790000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.920678,"shares":17790000,"dividePrice":1.4795,"high":16.51,"amplitude":0.013906,"preClose":16.54,"low":16.28,"week52Low":14.815,"pbRate":"--","week52High":19.35,"institutionHeld":0,"latestPrice":16.33,"eps":0,"divideRate":0.0906,"volume":294869,"delay":0,"ttmEps":0,"open":16.51,"prevYearClose":15.4324,"prevWeekClose":16.54,"prevMonthClose":16.64,"prevQuarterClose":16.64,"fiveDayClose":16.71,"twentyDayClose":17.94,"sixtyDayClose":18.5141},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KBWY\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"KBWY","amount":0.11987,"announcedDate":"2026-09-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"Invesco KBW Premium Yield Equity REIT ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-25"},{"date":"2026-08-24","symbol":"KBWY","amount":0.1199,"announcedDate":"2026-08-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-24","defaultRemindTime":1787578200000,"name":"Invesco KBW Premium Yield Equity REIT ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-28","payableDate":"2026-08-24","currency":"USD","dateTimestamp":1787544000000,"payDate":"2026-08-28"},{"date":"2026-07-20","symbol":"KBWY","amount":0.11998,"announcedDate":"2026-07-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-20","defaultRemindTime":1784554200000,"name":"Invesco KBW Premium Yield Equity REIT ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-24","payableDate":"2026-07-20","currency":"USD","dateTimestamp":1784520000000,"payDate":"2026-07-24"},{"date":"2026-06-22","symbol":"KBWY","amount":0.12001,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco KBW Premium Yield Equity REIT ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-05-18","symbol":"KBWY","amount":0.12252,"announcedDate":"2026-05-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-18","defaultRemindTime":1779111000000,"name":"Invesco KBW Premium Yield Equity REIT ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-22","payableDate":"2026-05-18","currency":"USD","dateTimestamp":1779076800000,"payDate":"2026-05-22"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KBWY\",market:\"US\",,,undefined,":[{"executeDate":"2016-10-14","recordDate":"2016-10-18","paymentDate":"2016-10-31","value":0.27757,"currency":"USD"},{"executeDate":"2016-11-15","recordDate":"2016-11-17","paymentDate":"2016-11-30","value":0.22626,"currency":"USD"},{"executeDate":"2016-12-15","recordDate":"2016-12-19","paymentDate":"2016-12-30","value":0.22488,"currency":"USD"},{"executeDate":"2017-01-13","recordDate":"2017-01-18","paymentDate":"2017-01-31","value":0.21316,"currency":"USD"},{"executeDate":"2017-02-15","recordDate":"2017-02-17","paymentDate":"2017-02-28","value":0.20398,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KBWY\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KBWY\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673737081","title":"Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504","url":"https://stock-news.laohu8.com/highlight/detail?id=2673737081","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673737081?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:05","pubTimestamp":1791230700,"startTime":"0","endTime":"0","summary":"On track to initiate dosing by early November 2026; topline Phase 1 proof-of-mechanism data anticipated approximately six months following study initiation Randomized, double-blind, placebo-controlled","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/05/3374999/0/en/equillium-receives-australian-regulatory-clearance-to-initiate-first-in-human-clinical-trial-of-eq504.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","KBWY","LU1169589451.USD","PD","BK4181","LU1169590202.USD","BK4218","PK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673702771","title":"Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly","url":"https://stock-news.laohu8.com/highlight/detail?id=2673702771","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673702771?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:00","pubTimestamp":1791201600,"startTime":"0","endTime":"0","summary":"Trial follows promising MAR002 Phase 1 clinical trial results that demonstrated deep and durable IGF-1 suppression with PK properties that may enable dosing as infrequently as once every two weeks, co","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/05/3374474/18623/en/marea-therapeutics-a-subsidiary-of-lisata-therapeutics-announces-first-patient-dosed-in-phase-2-clinical-trial-of-mar002-a-potential-best-in-disease-investigational-therapy-for-the.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","PTH","BK4551","GDOC","BK4218","PK","BK4585","GNMX","BK4181","BK4183","BK4539","FFOX","LU0889565916.HKD","GNOM","LU0320765992.SGD","KBWY","BK4007","LU0109394709.USD","BK4139","BK4535","ENDO","BK4196","EKG","HELX","LENZ","GH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672944717","title":"Climb Bio to Present New Data at American Society of Nephrology (ASN) Kidney Week 2026 for CLYM116 and Budoprutug","url":"https://stock-news.laohu8.com/highlight/detail?id=2672944717","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672944717?lang=en_us&edition=fundamental","pubTime":"2026-10-02 21:30","pubTimestamp":1790947800,"startTime":"0","endTime":"0","summary":"Preliminary Phase 2 data from the ongoing PrisMN study of budoprutug in primary membranous nephropathy selected for oral presentation Presentations on CLYM116 and budoprutug programs highlight advance","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/02/3373844/0/en/climb-bio-to-present-new-data-at-american-society-of-nephrology-asn-kidney-week-2026-for-clym116-and-budoprutug.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4199","BK4107","BK4566","PMN","IE00BJJMRX11.SGD","LU0795875086.SGD","BK4209","BK4181","IE0004445015.USD","LU0868494708.USD","LU1169589451.USD","LU0726765562.USD","BK4581","LU1069347547.HKD","AFG","LU2347655073.USD","BK4023","BK4218","BK4504","LU1430594728.SGD","BK4585","IE00B7KXQ091.USD","MCD","LU1244550494.USD","LU0868494617.USD","LU1732800096.USD","LU0795875169.SGD","LU1732799900.SGD","LU1585245621.USD","LU1074936037.SGD","BK4610","LU1169590202.USD","BK4550","IE00BJTD4V19.USD","PK","LU0942090050.USD","LU1035773651.USD","LU0256863811.USD","BK4117","LU2347655156.SGD","BK4534","SLE","BK4139","PD","KBWY","LU1244550221.USD","ITP","LU0417517546.SGD","IE00BJJMRY28.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672571915","title":"Innovative Industrial Properties initiated with an Outperform at Huntington","url":"https://stock-news.laohu8.com/highlight/detail?id=2672571915","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672571915?lang=en_us&edition=fundamental","pubTime":"2026-10-02 19:15","pubTimestamp":1790939715,"startTime":"0","endTime":"0","summary":"Huntington initiated coverage of Innovative Industrial Properties (IIPR) with an Outperform rating and $60 price target Published first on TheFly –...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/innovative-industrial-properties-initiated-with-an-outperform-at-huntington-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/innovative-industrial-properties-initiated-with-an-outperform-at-huntington-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4171","KBWY","BK4224","PRTO","IIPR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":45,"pageCount":1,"totalSize":177,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/KBWY\",params:#limit:6,delay:false,,,undefined,":[]}}